Hospital Universitari Arnau de Vilanova

Lleida, Catalonia 25198

0 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Locally Recurrent Breast Cancer, Metastatic Breast Cancer, Multiple Sclerosis, Relapsing-Remitting, Type 1 Diabetes Mellitus

Studies at this site

• A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab Administration — Completed
• Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer — Stopped early
• A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy — Completed
• Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer — Completed